-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PSakahXCbob0Cjy3CfaMfO/EBxQmTJe+zgscw551s1DTAYjPhctayp1rp7ubP+zL uYdRrZlDbsqD1tShneDcfg== 0000919722-09-000002.txt : 20091104 0000919722-09-000002.hdr.sgml : 20091104 20091103213749 ACCESSION NUMBER: 0000919722-09-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091104 DATE AS OF CHANGE: 20091103 EFFECTIVENESS DATE: 20091104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERGEN INC CENTRAL INDEX KEY: 0000919722 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911841574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-91972-2L FILM NUMBER: 091156095 BUSINESS ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 BUSINESS PHONE: 9255600100 MAIL ADDRESS: STREET 1: 4140 DUBLIN BLVD STREET 2: STE 200 CITY: DUBLIN STATE: CA ZIP: 94568 D 1 primary_doc.xml X0603 D LIVE 0000919722 SUPERGEN INC 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100 DELAWARE None None Corporation true James S.J. Manuso c/o SuperGen, Inc. 4140 Dublin Blvd., Suite 200 Dublin CA 94568 Executive Officer Director Charles J. Casamento c/o The Sage Group P.O. Box 949 Kenwood CA 95452 Director Thomas V. Girardi c/o Girardi & Keese 1126 Wilshire Blvd. Los Angeles CA 90017-1904 Director Allan R. Goldberg 719 Downing Street Teaneck NJ 07666-2220 Director Walter J. Lack c/o Engstrom Lipscomb & Lack 10100 Santa Monica Blvd., 16th Floor Los Angeles CA 90067-4107 Director Michael D. Young 16 Le Fleur Arbordeau 500 Berwin Baptist Road Devon PA 19333 Director Mohammad Azab c/o SuperGen, Inc. 4140 Dublin Blvd., Suite 200 Dublin CA 94568 Executive Officer Michael Molkentin c/o SuperGen, Inc. 4140 Dublin Blvd., Suite 200 Dublin CA 94568 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2009-10-22 false true false 0 3000000 3000000 0 false 1 0 0 0 false SUPERGEN INC Michael Molkentin Michael Molkentin Chief Financial Officer 2009-11-03 -----END PRIVACY-ENHANCED MESSAGE-----